Navidea Biopharma (NAVB) Reports Q1 Loss of $0.24

Navidea Biopharma (NYSE: NAVB) reported Q1 EPS of ($0.24), versus ($0.83) reported last year. Revenue for the quarter came in at $136 thousand, versus $275.65 thousand reported last year.

For earnings history and earnings-related data on Navidea Biopharma (NAVB) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Ennis (EBF) Reports In-Line Q1 EPS
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance